Hormone therapy for postmenopausal endometrial cancer survivors: A survey among Greek obstetricians-gynaecologists

European Journal of Gynaecological Oncology

Volumn 32, Issue 1, 2011, Pages 81-83

  Vavilis, D ^a   Tsolakidis, D ^a   Goulis, D G ^a   Polichronou, P ^a   Kellartzis, D ^a   Tzevelekis, P ^a   Tarlatzis, B C ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Endometrial cancer survivors; Estrogen replacement therapy; Estrogen progestogen combination; Hormone replacement therapy; Prescription attitude; Tibolone

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CENTRAL NERVOUS SYSTEM AGENTS; ESTROGEN; GESTAGEN; PHYTOESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SURVIVOR; ENDOMETRIUM CANCER; FEMALE; GREECE; HUMAN; MALE; MEDICAL PRACTICE; MEDICAL SPECIALIST; NORMAL HUMAN; PHYSICIAN ATTITUDE; POSTMENOPAUSE; PRESCRIPTION; QUESTIONNAIRE; SEX DIFFERENCE; TREATMENT INDICATION; VALIDATION PROCESS;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GREECE; GYNECOLOGY; HUMANS; MIDDLE AGED; OBSTETRICS; POSTMENOPAUSE; QUESTIONNAIRES; SURVIVORS;

EID: 79952347050     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Barakat R.R.: "Contemporary issues in the management of endometrial cancer". CA Cancer J. Clin., 1998, 48, 299.
2. Daayana S., Holland C.M.: "Hormone replacement therapy and the endometrium". Menopause Int., 2009, 15, 134.
3. Wren B.G.: "Hormonal therapy following female genital tract cancer". Int. J. Gynecol. Cancer, 1994, 4, 212.
4. Creasman W.T., Henderson D., Hinshaw W., Clarke-Pearson D.L.: "Estrogen replacement therapy in the patient treated for endometrial cancer". Obstet. Gynecol., 1986, 67, 326.
5. Byrant G.W.: "Administration of estrogens to patients with a previous diagnosis of endometrial adenocarcinoma". South Med. J., 1990, 83, 725.
6. Baker D.D.: "Estrogen replacement therapy in patient with previous endometrial carcinoma". Compr. Ther., 1990, 16, 28.
7. Lee R.B., Burke T.W., Park R.C.: "Estrogen replacement therapy following treatment for Stage I endometrial carcinoma". Gynecol. Oncol., 1990, 36, 189.
8. Chapman J.A., DiSaia P.J., Osann K., Roth P.D., Gillotte D.L., Berman M.L.: "Estrogen replacement in surgical Stage I and II endometrial cancer survivors". Am. J. Obstet. Gynecol., 1996, 175, 1195.
9. Suriano K.A., McHale M., McLaren C.E., Li K.T., Re A., DiSaia P.J.: "Estrogen replacement therapy in endometrial cancer patients: a matched control study". Obstet. Gynecol., 2001, 97, 555.
10. Ayhan A., Taskiran C., Simsek S., Sever A.: "Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?". Int. J. Gynecol. Cancer, 2006, 16, 805.
11. Barakat R.R., Brundy B.N., Spirtos N.M., Bell J., Mannel R.S.: "Randomized double-blind trial of estrogen replacement therapy versus placebo in Stage I or II endometrial cancer: a Gynaecological Oncology Group study". J. Clin. Oncol., 2006, 24, 587.
12. Rozenberg S., Vasquez J.B.: "Estrogen replacement therapy in patients with endometrial cancer: prescription attitude of Belgian gynecologists". Maturitas, 2000, 35, 125.
13. Singh P., Oehler M.K.: "Hormone replacement after gynaecological cancer". Maturitas, 2010, 65, 190.
14. ACOG Committee Opinion: "Hormone replacement therapy in women treated for endometrial cancer". In: Committee on Gynaecologic Practice, No 235, May 2000. The American College of Obstetricians and Gynecologists, Washington, DC.
15. Writing Group for the Women's Health Initiative Investigators: "Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health Initiative randomized controlled trial". JAMA, 2002, 288, 321.
16. Million Women Study Collaborators: "Endometrial cancer and hormone-replacement therapy in the Million Women Study". Lancet, 2005, 365, 1543.
17. Blok L.J., De Ruiter P.E., Kuhne E.C: "Progestogenic effects of tibolone on human endometrial cancer cells". J. Clin. Endocrinol. Metab., 2003, 88, 2327.
18. Hanifi-Moghaddam P., Gielen S.C., Koosterboer H.J.: "Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone". J. Clin. Endocrinol. Metab., 2005, 90, 973.